Azetidine-3-carboxylic acid
Azetidine-3-carboxylic acid

Produktübersicht
Kurzüberblick
- Produktfamilie
- ADC Linkers & Conjugation Reagents
- Chemischer Name
- Azetidine-3-carboxylic acid
- MF
- C4H7NO2
- MW
- 101.1
Azetidine-3-carboxylic acid is a small azetidine carboxylic acid identified by CAS 36476-78-5.
This record matches molecular formula C4H7NO2, molecular weight about 101.1, PubChem CID 93192, and InChIKey GFZWHAAOIVMHOI-UHFFFAOYSA-N.
The PubChem IUPAC name is azetidine-3-carboxylic acid.
Identität und Spezifikationen
| Catalog No. | CH53012 |
| CAS No. | 36476-78-5 |
| Chemical Name | Azetidine-3-carboxylic acid |
| Molecular Formula | C4H7NO2 |
| Molecular Weight | 101.1 |
| PubChem CID | 93192 |
| InChIKey | GFZWHAAOIVMHOI-UHFFFAOYSA-N |
Anwendungskontext
- Azetidine building-block identity: supports matching the azetidine carboxylic acid name with CAS 36476-78-5 and PubChem CID 93192.
- Catalog data alignment: useful when formula, molecular weight, CAS number, and InChIKey need to be checked together.
- Small heterocycle reference: provides a concise identity record for azetidine-3-carboxylic acid.
Weitere Materialinformationen
Verwendung
Useful for aligning Azetidine-3-carboxylic acid with CAS 36476-78-5, formula C4H7NO2, PubChem CID 93192, and the InChIKey GFZWHAAOIVMHOI-UHFFFAOYSA-N.
Eigenschaften
- Small nitrogen heterocycle bearing a carboxylic acid group at the 3-position.
- CAS and product-name lookups both resolve to PubChem CID 93192.
- The formula and molecular weight align between CHEMOS source data and PubChem.
Zugehörige technische Ressourcen
Öffentliche Quellen
- 3-azetidinecarboxylic Acid | PubChem CID 93192
- Development of Solid-Phase Site-Specific Conjugation and Its Application toward Generation of Dual Labeled Antibody and Fab Drug Conjugates
Bioconjugate Chemistry, 2016
Product-family technical context
- Effect of Linker-Drug Properties and Conjugation Site on the Physical Stability of ADCs
Journal of Pharmaceutical Sciences, 2020
Product-family technical context
- Antibody-Maytansinoid Conjugates Are Activated in Targeted Cancer Cells by Lysosomal Degradation and Linker-Dependent Intracellular Processing
Cancer Research, 2006
Product-family technical context
- The Effect of Different Linkers on Target Cell Catabolism and Pharmacokinetics/Pharmacodynamics of Trastuzumab Maytansinoid Conjugates
Molecular Cancer Therapeutics, 2012
Product-family technical context
Ähnliche Produkte
Benötigen Sie Hilfe bei der Materialauswahl?
CHEMOS kann Produktfit, Zielstruktur, Routenfragen, analytische Erwartungen und projektspezifische Lieferbedarfe prüfen.



